Alivus Life Sciences Limited has informed the Exchange about Schedule of meet.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has informed the stock exchange about its schedule for an upcoming meeting, likely an investor or analyst interaction. The filing itself is a routine compliance disclosure required by NSE listing norms. No specific date, venue, or agenda details are mentioned in the headline. Shareholders and analysts can expect further details in the formal intimation filed with the exchange.
This is a routine disclosure with no direct impact on stock price or shareholder value. It indicates ongoing investor engagement activities by the company, which is generally viewed as a positive governance signal.